OptimizeRx Corp OPRX
Nasdaq · stock · Services-Business Services, NEC · website · IPO 2005-05-18
OptimizeRx Corp statistics & valuation
Market cap$96.1M
P / E18.7×
P / S0.9×
P / B0.7×
P / FCF5.1×
Net margin4.7%
Return on equity4.0%
FCF margin17.0%
Net debt$2.9M
Net debt / EBITDA0.2×
Enterprise value USD$99.0M
EV / EBITDA6.2×
Earnings yield EBIT/EV11.8%
Return on capital7.5%
Graham number -9%$6.40
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($6.40); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 67.3% | 64.5% | 60.0% | — | 62.4% | 58.1% | 55.7% | 62.8% | 57.6% | 49.1% |
| Operating margin | 10.7% | -14.9% | -36.9% | — | -19.7% | 0.6% | -4.9% | -15.0% | 0.8% | -17.6% |
| Net margin | 4.7% | -21.8% | -24.6% | — | -18.3% | 0.6% | -5.1% | -12.8% | 1.1% | -17.3% |
| FCF margin | 17.0% | 5.2% | -10.2% | — | 16.9% | 1.0% | -14.7% | -7.1% | 3.6% | -12.6% |
| Return on assets | 2.9% | -11.7% | -9.6% | — | -8.5% | 0.3% | -3.7% | -5.5% | 0.9% | -21.5% |
| Return on equity | 4.0% | -17.2% | -13.9% | — | -9.1% | 0.3% | -4.4% | -7.0% | 1.2% | -33.8% |
| Debt / equity | 0.20× | 0.29× | 0.30× | — | — | — | — | — | — | — |
| Current ratio | 3.04 | 2.89 | 3.04 | 15.44 | 11.74 | 12.29 | 3.28 | 4.44 | 3.72 | 2.49 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.